Finzati - Logo
ASND logo

Ascendis Pharma A/S

ASND • Biotechnology
$270.56
▼ -0.56 (-0.21%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$17.49B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 199.4%Positive free cash flow · 0.72Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:46 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$270.56
Change-0.21%
Shares Out64.52M
Market Cap$17.49B
52W Range186.05 - 282.15
Beta0.38
P/E5.25
P/S53.59
P/B27.50
P/FCF-856.33
EV/Sales49.99
EV/EBITDA424.59

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
34/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 199.4%Positive free cash flow · 0.72Weak profitability

Analyst view

Analyst sentiment and price target

ASND
Analyst sentiment
Based on 25 analyst votes · 2026-09-04
96/100
Bullish
Bullish
23
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$255.00
Mean
$301.90
Median
$313.00
High
$333.00

Company Overview

IPO: 1/28/2015
Industry: Biotechnology
P/B i: 27.50
Debt / Equity i: -5.35
Operating Margin: -18.92%
Net Margin: -31.67%
ROE i: -
ROIC: -

Financial Health

Score7 / 20
Debt / Equity: -5.35
Current Ratio: 1.04
Quick Ratio: 0.76
Status: Weak

Insider Transactions

Recent executive and insider activity

SMITH SCOTT THOMAS
Transaction: 06/02/2026
BUY
Change
+100
Price
$219.00
Filing
06/02/2026
Type
BUY
SMITH SCOTT THOMAS
Transaction: 05/29/2026
BUY
Change
+250
Price
$223.32
Filing
06/01/2026
Type
BUY
BIENAIME JEAN JACQUES
Transaction: 05/29/2026
BUY
Change
+200
Price
$223.76
Filing
06/01/2026
Type
BUY